Abstract
We analyzed Lewy body (LB) pathology in 18 autosomal dominant Alzheimer’s disease (ADAD) brains via immunohistochemistry. Real-time quaking induced conversion was used to detect misfolded α-synuclein (α-syn) in 18 living ADAD cerebrospinal fluid (CSF) samples. Concomitant LB pathology was present in 44% ADAD brains. Only 6% CSF samples were positive for misfolded α-syn. In an additional AD sample, all patients with confirmed LB presented misfolded α-syn in postmortem CSF regardless of the LB staging. In conclusion, misfolded α-syn in CSF was scarce in symptomatic living ADAD individuals, in contrast to postmortem brain tissue. These results suggest late appearance of LB pathology in ADAD.
Keywords
Get full access to this article
View all access options for this article.
References
1.
Sarto
J
,
Mayà
G
,
Molina-Porcel
L
,
Balasa
M
,
Gelpi
E
,
Aldecoa
I
,
Borrego-Écija
S
,
Contador
J
,
Ximelis
T
,
Vergara
M
,
Antonell
A
,
Sanchez-Valle
R
,
Lladó
A
, ; Neurological Tissue Bank, Biobanc-Hospital Clínic Barcelona-IDIBAPS CollaborativeGroup (2022 ) Evolution of clinical-pathological correlations inearly-onset Alzheimer’s disease over a 25-year period in an academic brain bank . J Alzheimers Dis 87 , 1659 –1669 .
2.
Twohig
D
,
Nielsen
HM
(2019 )
α-synuclein in the pathophysiology of Alzheimer’s disease . Mol Neurodegener 14 , 23 .
3.
Cairns
NJ
,
Perrin
RJ
,
Franklin
EE
,
Carter
D
,
Vincent
B
,
Xie
M
,
Bateman
RJ
,
Benzinger
T
,
Friedrichsen
K
,
Brooks
WS
,
Halliday
GM
,
McLean
C
,
Ghetti
B
,
Morris
JC
; Alzheimer Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network
(2015 ) Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN) . Neuropathology 35 , 390 –400 .
4.
Ringman
JM
,
Monsell
S
,
Ng
DW
,
Zhou
Y
,
Nguyen
A
,
Coppola
G
,
Van Berlo
V
,
Mendez
MF
,
Tung
S
,
Weintraub
S
,
Mesulam
MM
,
Bigio
EH
,
Gitelman
DR
,
Fisher-Hubbard
AO
,
Albin
RL
,
Vinters
HV
(2016 ) Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center Database . J Neuropathol Exp Neurol 75 , 284 –290 .
5.
Leverenz
JB
,
Fishel
MA
,
Peskind
ER
,
Montine
TJ
,
Nochlin
D
,
Steinbart
E
,
Raskind
MA
,
Schellenberg
GD
,
Bird
TD
,
Tsuang
D
(2006 ) Lewy body pathology in familial Alzheimer disease: Evidence for disease- and mutation-specific pathologic phenotype . Arch Neurol 63 , 370 –376 .
6.
Iranzo
A
,
Fairfoul
G
,
Ayudhaya
ACN
,
Serradell
M
,
Gelpi
E
,
Vilaseca
I
,
Sanchez-Valle
R
,
Gaig
C
,
Santamaria
J
,
Tolosa
E
,
Riha
RL
,
Green
AJE
(2021 ) Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: A longitudinal observational study . Lancet Neurol 20 , 203 –212 .
7.
Fairfoul
G
,
McGuire
LI
,
Pal
S
,
Ironside
JW
,
Neumann
J
,
Christie
S
,
Joachim
C
,
Esiri
M
,
Evetts
SG
,
Rolinski
M
,
Baig
F
,
Ruffmann
C
,
Wade-Martins
R
,
Hu
MT
,
Parkkinen
L
,
Green
AJ
(2016 ) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies . Ann Clin Transl Neurol 3 , 812 –818 .
8.
Ximelis
T
,
Marín-Moreno
A
,
Espinosa
JC
,
Eraña
H
,
Charco
JM
,
Hernandez
I
,
Riveira
C
,
Alcolea
D
,
Gonzalez-Roca
E
,
Aldecoa
I
,
Molina-Porcel
L
,
Parchi
P
,
Rossi
M
,
Castilla
J
,
Ruiz-García
R
,
Gelpi
E
,
Torres
JM
,
Sanchez-Valle
R
(2021 ) Homozygous R136S mutation in PRNP genecauses inherited early onset prion disease . Alzheimers ResTher 13 , 176 .
9.
Hyman
BT
,
Phelps
CH
,
Beach
TG
,
Bigio
EH
,
Cairns
NJ
,
Carrillo
MC
,
Dickson
DW
,
Duyckaerts
C
,
Frosch
MP
,
Masliah
E
,
Mirra
SS
,
Nelson
PT
,
Schneider
JA
,
Thal
DR
,
Thies
B
,
Trojanowski
JQ
,
Vinters
HV
,
Montine
TJ
(2012 ) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease . Alzheimers Dement 8 , 1 –13 .
10.
McKeith
IG
,
Boeve
BF
,
Dickson
DW
,
Halliday
G
,
Taylor
JP
,
Weintraub
D
,
Aarsland
D
,
Galvin
J
,
Attems
J
,
Ballard
CG
,
Bayston
A
,
Beach
TG
,
Blanc
F
,
Bohnen
N
,
Bonanni
L
,
Bras
J
,
Brundin
P
,
Burn
D
,
Chen-Plotkin
A
,
Duda
JE
,
El-Agnaf
O
,
Feldman
H
,
Ferman
TJ
,
Ffytche
D
,
Fujishiro
H
,
Galasko
D
,
Goldman
JG
,
Gomperts
SN
,
Graff-Radford
NR
,
Honig
LS
,
Iranzo
A
,
Kantarci
K
,
Kaufer
D
,
Kukull
W
,
Lee
VMY
,
Leverenz
JB
,
Lewis
S
,
Lippa
C
,
Lunde
A
,
Masellis
M
,
Masliah
E
,
McLean
P
,
Mollenhauer
B
,
Montine
TJ
,
Moreno
E
,
Mori
E
,
Murray
M
,
O’Brien
JT
,
Orimo
S
,
Postuma
RB
,
Ramaswamy
S
,
Ross
OA
,
Salmon
DP
,
Singleton
A
,
Taylor
A
,
Thomas
A
,
Tiraboschi
P
,
Toledo
JB
,
Trojanowski
JQ
,
Tsuang
D
,
Walker
Z
,
Yamada
M
,
Kosaka
K
(2017 ) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium . Neurology 89 , 88 –100 .
11.
Antonell
A
,
Tort-Merino
A
,
Ríos
J
,
Balasa
M
,
Borrego-Écija
S
,
Auge
JM
,
Muñoz-García
C
,
Bosch
B
,
Falgàs
N
,
Rami
L
,
Ramos-Campoy
O
,
Blennow
K
,
Zetterberg
H
,
Molinuevo
JL
,
Lladó
A
,
Sanchez-Valle
R
(2020 ) Synaptic, axonal damage andinflammatory cerebrospinal fluid biomarkers in neurodegenerativedementias . Alzheimers Dement 16 , 262 –272 .
12.
Hall
S
,
Orrù
CD
,
Serrano
GE
,
Galasko
D
,
Hughson
AG
,
Groveman
BR
,
Adler
CH
,
Beach
TG
,
Caughey
B
,
Hansson
O
(2022 ) Performance ofαSynuclein RT-QuIC in relation to neuropathological stagingof Lewy body disease . Acta Neuropathol Commun 10 , 90 .
13.
Quadalti
C
,
Palmqvist
S
,
Hall
S
,
Rossi
M
,
Mammana
A
,
Janelidze
S
,
Dellavalle
S
,
Mattsson-Carlgren
N
,
Baiardi
S
,
Stomrud
E
,
Hansson
O
,
Parchi
P
(2023 ) Clinical effects of Lewy body pathology in cognitively impaired individuals . Nat Med 29 , 1964 –1970 .
14.
Quadalti
C
,
Calandra-Buonaura
G
,
Baiardi
S
,
Mastrangelo
A
,
Rossi
M
,
Zenesini
C
,
Giannini
G
,
Candelise
N
,
Sambati
L
,
Polischi
B
,
Plazzi
G
,
Capellari
S
,
Cortelli
P
,
Parchi
P
(2021 ) Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes . NPJ Parkinsons Dis 7 , 93 .